Balloon catheter with non-deployable stent

Information

  • Patent Grant
  • 11571554
  • Patent Number
    11,571,554
  • Date Filed
    Tuesday, June 5, 2012
    12 years ago
  • Date Issued
    Tuesday, February 7, 2023
    a year ago
Abstract
An angioplasty balloon including a non-deployable stent to prevent or reduce the potential for slippage of the inflated balloon with respect to the vessel wall being treated. The balloon includes a non-deployable stent that is adapted to be secured to the balloon or angioplasty balloon catheter. The stent has a proximal end, a distal end, and at least three radially-spaced struts, each, each strut connecting the proximal end to the distal end and having one or more bends that allow expansion of the strut to accommodate the inflation of the balloon. The stem is made or a material so that the stent collapses upon deflation of the balloon.
Description
BACKGROUND OF THE INVENTION

When a balloon used for percutaneous transluminal angioplasty (PTA) or percutaneous transluminal coronary angioplasty (PTCA) is inflated and forced into contact with the plaque, the balloon can have a tendency to move or slip longitudinally in relation to the lesion or the vessel wall being treated.


Cutting balloons (atherotomy) have recently shown clinical efficacy in preventing the reoccurrence of some types of restenosis (specifically calcified lesions and instent restenosis). The cutting balloon is a coronary dilatation catheter with 3 to 4 atherotomes (microsurgical blades) bonded longitudinally on the balloon surface. As the cutting balloon is inflated, the atherotomes move radially and open the occluded artery by incising and compressing the arterial plaque in a controlled manner. An additional advantage of the cutting balloon is that it maintains its position during inflation by using the metal blades on the external surface of the balloon to penetrate into the tissue and prevent the balloon from moving.


Accordingly, it is the principal objective of the present invention to provide a PTA or PTCA balloon that, like a cutting balloon, has a reduced potential of slippage when inflated in a vessel.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of an inflated angioplasty balloon incorporating a non-deployable stent according to the present invention.



FIG. 2 is a plan view of the inflated angioplasty balloon and non-deployable stent of FIG. 1.



FIG. 3 is a perspective view of the non-deployable stent in its expanded condition, as shown in FIG. 1, with the angioplasty balloon removed so as to more clearly show the stent.



FIG. 4 is a plan view of the non-deployable stent of FIG. 3.



FIG. 5 is a perspective view of an alternate embodiment of the non-deployable stent associated with an angioplasty balloon that has a longer working length than the angioplasty balloon shown in FIGS. 1 and 2.



FIG. 6 is an engineering drawing showing, in plan view, the layout of a non-deployable stent adapted to be used with an angioplasty balloon of 20 mm in length. (All dimensions shown in the drawing are in inches.)



FIG. 7 is a perspective view of an inflated angioplasty balloon incorporating an alternative embodiment of a non-deployable stent which does not include any connecting elements between the struts intermediate the ends of the balloon.



FIG. 8 is a perspective view of the non-deployable stent shown in FIG. 7, with the angioplasty balloon removed so as to more clearly show the stent.



FIGS. 9 and 10 are perspective views similar to FIGS. 1, 5, and 7 showing a further embodiment of the invention.



FIG. 11 is a perspective view of a further embodiment of the present invention showing the balloon and non-deployable stent in conjunction with a catheter.



FIG. 12 is an engineering drawing showing, in plan view, the layout of another embodiment of a non-deployable stent adapted to be used with an angioplasty balloon, in accordance with the present invention.



FIG. 13 is an engineering drawing showing, in plan view, the layout of an alternate non-deployable stent of the embodiment in FIG. 12.





DETAILED DESCRIPTION OF THE INVENTION

The non-deployable stent of the present invention may be used in conjunction with a conventional balloon catheter, A PTA or PTCA catheter (dilatation catheter) may be a coaxial catheter with inner and outer members comprising a guide wire lumen and a balloon inflation lumen, respectively. Each member can have up to 3 layers and can be reinforced with braids. The proximal end of the catheter has a luer hub for connecting an inflation means, and a strain relief tube extends distally a short distance from the luer hub. The distal ends of the outer and inner members may include a taper. The catheter shaft is built using conventional materials and processes. A catheter having multi-durometer tubing with variable stiffness technology is also a possibility. The catheter should be compatible with a 6F guide catheter. Optionally, the catheter may be a multi-lumen design.


The balloon 1 may be made of either nylon or nylon copolymer (compliant, non-puncture) or PET (high pressure, non-compliant) with a urethane coating to provide tackiness. The balloon may be a multi-layered balloon with a noncompliant inner layer to a most compliant outer layer. For example, an inner most layer of PET, which provides a higher pressure balloon, surrounded by an outer layer of nylon, which provides a more puncture-resistant surface. The balloon may be from 1.5-12 mm in diameter (1.5-4 mm for coronary and 4-12 mm for peripheral vessels) and 15-60 mm in length (15-40 mm for coronary and up to 60 mm for peripheral vessels). The balloon inflation pressure will be from 8-20 atmospheres, depending on the wall thickness of the balloon. When inflated, the balloon ends or necks are cone-shaped.


In keeping with the invention, the balloon is provided with a Nitinol (NiTi) structure, generally designated 2, that incorporates bends for both radial and longitudinal expansion of the Nitinol structure 2 in response to longitudinal and radial expansion of the balloon during inflation, so that the Nitinol structure 2 maintains the balloon in its intended position during inflation. This Nitinol structure 2 can be described as a non-deployable or temporary stent that provides for both controlled cracking of vessel occlusion and gripping of vessel wall during an angioplasty procedure. The Nitinol structure 2 comprises a laser cut hypo tube that expands upon inflation of the balloon, but collapses upon deflation of the balloon because of the super-elastic properties of the Nitinol material, rather than remain expanded in the deployed condition, as would stents in general.


The Nitinol structure or non-deployable stent 2 has a proximal end 3, a distal end 4, and, therebetween, anywhere from 3-12 struts or wires 5 (depending on balloon size—but most likely 3-4 struts) with a pattern of radial and longitudinal bends. The use of laser cutting in connection with stent manufacture is well known (See, e.g., Meridan et al. U.S. Pat. No. 5,994,667), as is the use of the super-elastic nickel-titanium alloy Nitinol (see e.g., Huang et al. U.S. Pat. No. 6,312,459).


As seen in FIGS. 1-4, each end of the four struts 5 has a sinusoidal bend 6 that allows the laser cut hypo tube to expand longitudinally when the balloon 1 is inflated. The linear length of the sinusoidal bends 6 is sized to accommodate the longitudinal expansion of the balloon 1 due to inflation. The strut or wire 5 cross sectional shape can be round, triangular or rectangular. Preferred diameter of the struts 5 ranges from 0.003 to 0.010 inch.


At the longitudinal center of the hypo tube, a U-shaped circumferential connector 7 joins each strut 5 to its adjacent strut. As best seen in FIGS. 3 and 4, the U-shaped connectors 7 are on opposing sides of the central radial axis, and connectors 7 are joined to struts 5 at intersecting angles of 90 degrees. The distal end 4 of the hypo tube is adhered to the distal neck of the balloon or the distal end of the catheter shaft, and the proximal end 3 of the hypo tube is either attached to the proximal neck of the balloon or to the proximal end of the catheter shaft. The struts 5 may be attached to the working region of the balloon 1 to assist the hypo tube in staying with the balloon as it inflates and deflates, and an adhesive, such as a cyanoacrylate adhesive, may be used to tack the struts down onto balloon at various points.


Catheter shafts to which the balloon and laser cut hypo tube are attached can have diameters ranging from 2.5F to 8F, and the distal end may be tapered and slightly less in diameter than the proximal end.


In FIG. 6, the dimensions of the laser cut hypo tube are for use with a 3 mm (0.118 in) diameter by 20 mm length balloon. The circumference of a 3 rom balloon is nD=3.14(3 mm) 9.42 mm or 0.37 in. As can be readily appreciated, the total length of all U-shaped connectors 7 (up and back) must be greater than the circumference of the inflated balloon 1. The length of each U-shaped connector 7 (up and back), may be calculated using the following equation: where d is the diameter of the inflated balloon and n is the number of struts. The total length of the U-shaped bends (up and back) must exceed this length.


The resulting number is divided by 2 to get the length which each up-and-back side of the U-shaped connector should exceed. For example: for a 3 mm balloon compatible, laser-cut hypo tube with four struts, the length of each U-shaped connector (up and back) is 0.37 inch divided by 4=0.0925 in. Further divide by 2 and to get 0.04625 in. This is the length that each side of the U-shaped connector must exceed.


There is also one or more sets of U-shaped connectors 7 in between the sinusoidal bends 6. The set includes one U-shaped connector for each strut (3 struts—a set of 3 U-shaped connectors; 4 struts—a set of 4 U-shaped connector; and so on). The number of U-shaped connector sets depends on the length of the balloon and thus, the length of the laser cut hypo tube. For a 20 mm length balloon, there is one set of U-shaped connectors spaced 10 mm from the end (at the halfway point along length of balloon). For a 40 mm length balloon, there are three sets of U-shaped connectors spaced in 10 mm increments (the first set is spaced 10 mm from one end; the second set is spaced 10 mm from first set; and the third set is spaced 10 mm from each the second set and the other end). The equation for number of sets of U-shaped connectors.







L
10

-
1





where L=length of balloon in mm. Other embodiments, such as those shown in FIGS. 7 and 8, do not incorporate the intermediate U-shaped connectors.



FIG. 12 is directed to another embodiment of a non-deployable stent 102 which can be used with a conventional balloon catheter, in accordance with the present invention. The stent of this embodiment preferably has a Nitinol structure, though other materials can be used as discussed supra, that incorporates bends for both radial and longitudinal expansion of the stent in response to radial and longitudinal expansion of the balloon during inflation, so that the stent 102 maintains the balloon in its intended position. Similar to the stents of the other embodiments of the present invention discussed supra, the stent comprises a laser cut hypo tube that expands upon inflation of the balloon and collapses upon deflation of the balloon. Further, the stent is preferably secured to the balloon with some type of anchoring means. Preferably, such anchoring means are utilized at the ends of the stent and around the neck of the balloon. Examples of such anchoring means are utilized at the ends of the stent and around the neck of the balloon. Examples of such anchoring means include an adhesive such as for example a UV adhesive, cyanoacrylate, or a two-part epoxy, RF heat welding, solvent bonding, or crimping or swaging the ends of the stent to the shaft. Alternatively, a mechanical anchoring means can be used to anchor the stent to the balloon. With such a means, a small sleeve made of a similar material as the shaft of the catheter is mounted over the ends of the stent and heat welded together where the ends of the stent are sandwiched between the shaft and the sleeve.



FIG. 12 shows the hypo tube of the stent in an unrolled (flat) and non-extended state. The stent 102 has a proximal end 103 and a distal end 104. At each end, there are cage mounted flanges 110. These flanges can be used to attach the stent to the neck of the balloon. The flanges also spring open radially to permit insertion of the balloon during assembly. Between the ends, the stent 102 includes extension sections 112, serpentine rings 114 and elongation links 116.


Serpentine rings 114 have a serpentine shape and allow the stent 102 to expand radially when a balloon in the stent is inflated. However, as the balloon expands, the serpentine rings 114 will shorten in length. Accordingly, extension sections 112 and elongation links 116 expand longitudinally to compensate for any shortening of the length of the serpentine rings 114. Preferably, elongation links 116 have a z-shape, s-shape or accordion shape, as shown in FIG. 12.



FIG. 13 is an alternative embodiment showing a stent 202 having the same features as the stent in FIG. 12 except that stent 202 in FIG. 13 has elongated links 216 with a different pattern than the elongated links 116 in stent 102 of FIG. 12. More specifically, elongated links 216 have a zig zag pattern. Stent 202 of FIG. 13 operates in a substantially similar manner to that of stent 102 in FIG. 12.


While the present invention is not limited in the number of serpentine rings, extension sections and elongated links used in the stent, FIG. 13 illustrates a preferred embodiment. The stent 202 in FIG. 13 has from proximal end 103 to distal end 104, a first extension section 112, a first set of serpentine rings 114, a first set of elongated links 216, a second set of serpentine rings 114, a second set of elongated links 216, a third set of serpentine rings 114, a third set of elongated links 216, a fourth set of serpentine rings 114, and a second extension section 112.



FIG. 13 also shows an example of possible dimensions, in inches, of each of the components of the stent 202. These dimensions would also be used for each of the similar components in stent 102 in FIG. 12.


It will be understood that the embodiments and examples of the present invention, which have been described, are illustrative of some of the applications of the principles of the present invention. Numerous modifications may be made by those skilled in the art without departing from the true spirit and scope of the invention.

Claims
  • 1. A system for performing angioplasty, said system comprising: a catheter shaft having a distal end and an inflatable balloon disposed adjacent the distal end, wherein the inflatable balloon comprises a working length; andan expandable constraining structure disposed over the inflatable balloon, wherein the expandable constraining structure comprises a plurality of axial struts and at least one ring, wherein each of the axials struts comprise a central portion, wherein the ring is disposed over the working length of the inflatable balloon and intersects the central portions of the axial struts, said expandable constraining structure having a non-expanded configuration and an expanded configuration, wherein the non-expanded configuration comprises the expandable constraining structure lying closely over the inflatable balloon prior to inflation of the inflatable balloon, wherein the expanded configuration comprises the expandable constraining structure being smaller than an unconstrained size of the expandable balloon upon inflation of the inflatable balloon so that the expandable constraining structure restrains the inflatable balloon along a plurality of crossing channel lines, wherein the axial struts are joined to the catheter on a distal side of the balloon and a proximal side of the balloon wherein both ends of said constraining structure are fixedly attached to the catheter shaft.
  • 2. A system as in claim 1, wherein the channel lines are oriented axially, circumferentially, or both axially and circumferentially.
  • 3. A system as in claim 2, wherein the expandable constraining structure comprises a multiplicity of axially spaced-apart radially expandable rings attached to the axial struts, wherein the axial struts are circumferentially spaced-apart and cross the radially expandable rings.
  • 4. A system as in claim 3, wherein the rings are joined to the struts at intersecting angles of 90°.
  • 5. A system as in claim 3, wherein the radially expandable rings are composed of an elastic material which can elongate to allow the rings to expand when the inflatable balloon is inflated.
  • 6. A system as in claim 5, wherein the radially expandable rings are formed with deformable features which allow their radial expansion when the balloon is inflated.
  • 7. A system as in claim 6, wherein the deformable features comprise one or more of zig-zags, S-curves, and coils.
  • 8. A system as in claim 1, wherein the axial struts are each elastic in tension so that they will elongate as the inflatable balloon inflates.
  • 9. A method for treating a lesion in a blood vessel, said method comprising: inflating a balloon and expanding an expandable constraining structure, within the blood vessel, wherein the expandable constraining structure comprises a plurality of circumferentially spaced-apart axial struts and a plurality of axially spaced-apart radially expandable rings wherein the axial struts cross the rings, thereby creating openings in the expandable constraining structure, the plurality of axially spaced-apart radially expandable rings comprising a distal ring, a proximal ring and an intermediate ring between the distal ring and proximal ring, wherein the axial struts are joined to the catheter on a distal side of the balloon and a proximal side of the balloon; wherein both ends of said constraining structure are fixedly attached to the catheter shaft; andconstraining the balloon inflation along a plurality of crossing channel lines formed by said axial struts and said rings, whereupon inflation of the balloon, the expandable constraining structure has a configuration smaller than an unconstrained size of the balloon.
  • 10. A method as in claim 9, wherein the balloon is composed of a non-distensible or semi-compliant material and is inflated to a pressure in the range from 10 atm. to 25 atm.
  • 11. A method as in claim 9, wherein the balloon is constrained along crossing axial and circumferential channel lines to form quadrangular isolated protruding regions.
  • 12. A method as in claim 9, wherein a plurality of protruding regions have similar sizes and are uniformly distributed over the balloon surface.
  • 13. A system for performing angioplasty, said system comprising: a catheter shaft having an inflatable balloon adjacent its distal end; andan expandable constraining structure disposed over the inflatable balloon, wherein both ends of said constraining structure are directly affixed attached to the catheter shaft, the expandable constraining structure comprising a plurality of circumferentially spaced-apart axial struts and a plurality of axially spaced-apart radially expandable rings coupled to the axial struts, the plurality of axially spaced-apart radially expandable rings comprising a distal ring, a proximal ring and an intermediate ring between the distal ring and proximal ring, wherein a portion of the axial struts is un-affixed to the inflatable balloon, wherein the axial struts cross the radially expandable rings, wherein the expandable constraining structure comprises a non-expanded configuration and an expanded configuration, wherein the expandable constraining structure is in the non-expanded configuration when the inflatable balloon is in a deflated state and the expandable constraining structure is in the expanded configuration when the inflatable balloon is in an inflated state, whereupon the expandable constraining structure being in the non-expanded configuration, the expandable constraining structure lies closely over the inflatable balloon, and whereupon the expandable constraining structure being in the expanded configuration, the expandable constraining structure restrains inflation of the inflatable balloon along the axial struts.
  • 14. The system of claim 13, whereupon the expandable constraining structure being in the non-expanded configuration, the expandable constraining structure comprises a different configuration than the inflatable balloon in the deflated state.
  • 15. The system of claim 14, whereupon the expandable constraining structure being in the expanded configuration, the expandable constraining structure comprises a different configuration than the inflatable balloon in the inflated state.
  • 16. The system of claim 13, whereupon the expandable constraining structure being in the expanded configuration, the expandable constraining structure comprises a different configuration than the inflatable balloon in the inflated state.
  • 17. A system as in claim 3, wherein the multiplicity of axially spaced-apart radially expandable rings comprises a distal ring, a proximal ring and an intermediate ring between the distal ring and proximal ring and the intermediate ring is the at least one ring.
  • 18. A system as in claim 17, wherein the distal ring, the proximal ring and the intermediate ring are disposed over a working length of the inflatable balloon.
CROSS-REFERENCES TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 13/022,489, filed Feb. 7, 2011, which is a continuation of U.S. application Ser. No. 11/292,426, filed Dec. 1, 2005, now U.S. Pat. No. 7,931,663, which is a continuation of U.S. application Ser. No. 10/651,557, filed Aug. 29, 2003, now abandoned, which was a continuation-in-part of U.S. patent application Ser. No. 10/399,589, filed Apr. 18, 2003, now U.S. Pat. No. 7,691,119, which is the U.S. National Stage of PCT Application No. PCT/US02/35547, filed Nov. 6, 2002, which claimed the benefit of U.S. Provisional Application Ser. No. 60/344,982, filed on Nov. 9, 2001, the full disclosures of which are incorporated herein by reference. U.S. application Ser. No. 12/694,163, filed Jan. 26, 2010, as a continuation of U.S. application Ser. No. 10/399,589, filed Apr. 18, 2003, is also a related application.

US Referenced Citations (408)
Number Name Date Kind
2701559 Cooper Feb 1955 A
2854983 Baskin Oct 1958 A
3045677 Wallace Jul 1962 A
3467101 Fogarty et al. Sep 1969 A
3825013 Craven Jul 1974 A
4327736 Inoue May 1982 A
4456011 Warnecke Jun 1984 A
4483340 Fogarty et al. Nov 1984 A
4604762 Robinson Aug 1986 A
4637396 Cook Jan 1987 A
4649922 Wiktor Mar 1987 A
4723549 Wholey et al. Feb 1988 A
4733665 Palmaz Mar 1988 A
4796629 Grayzel Jan 1989 A
4838853 Parisi Jun 1989 A
4887613 Farr et al. Dec 1989 A
4895166 Farr et al. Jan 1990 A
4921484 Hillstead May 1990 A
4942788 Farr et al. Jul 1990 A
4950227 Savin et al. Aug 1990 A
4956830 Mock et al. Sep 1990 A
4969458 Wiktor Nov 1990 A
4976711 Parins et al. Dec 1990 A
4986807 Farr Jan 1991 A
4986830 Owens et al. Jan 1991 A
4998539 Delsanti Mar 1991 A
5003918 Olson et al. Apr 1991 A
5019088 Farr May 1991 A
5019089 Farr May 1991 A
5026384 Farr et al. Jun 1991 A
5062384 Foley et al. Nov 1991 A
5062648 Gomringer Nov 1991 A
5071407 Termin et al. Dec 1991 A
5098440 Hillstead Mar 1992 A
5100386 Inoue Mar 1992 A
5100423 Fearnot Mar 1992 A
5101682 Radisch et al. Apr 1992 A
5102402 Dror et al. Apr 1992 A
5102417 Palmaz Apr 1992 A
5108416 Ryan et al. Apr 1992 A
5112345 Farr May 1992 A
5116318 Hillstead May 1992 A
5120322 Davis et al. Jun 1992 A
5133732 Wiktor Jul 1992 A
5176693 Pannek, Jr. Jan 1993 A
5181911 Shturman Jan 1993 A
5190058 Jones et al. Mar 1993 A
5192291 Pannek et al. Mar 1993 A
5196024 Barath Mar 1993 A
5209727 Radisch et al. May 1993 A
5222971 Willard et al. Jun 1993 A
5224945 Pannek et al. Jul 1993 A
5224949 Gomringer et al. Jul 1993 A
5226887 Farr et al. Jul 1993 A
5243997 Uflacker et al. Sep 1993 A
5263963 Garrison et al. Nov 1993 A
5295493 Radisch et al. Mar 1994 A
5295959 Gurbel Mar 1994 A
5304121 Sahatjian Apr 1994 A
5306250 March et al. Apr 1994 A
5308354 Zacca et al. May 1994 A
5308356 Blackshear, Jr. May 1994 A
5318576 Plassche et al. Jun 1994 A
5320634 Vigil et al. Jun 1994 A
5336178 Kaplan Aug 1994 A
5336234 Vigil et al. Aug 1994 A
5344401 Radisch et al. Sep 1994 A
5344419 Spears Sep 1994 A
5350101 Godlewski Sep 1994 A
5423745 Todd et al. Jun 1995 A
5443078 Uflacker Aug 1995 A
5443446 Shturman Aug 1995 A
5443496 Schwartz et al. Aug 1995 A
5449372 Schmaltz Sep 1995 A
5449373 Pinchasik et al. Sep 1995 A
5456666 Campbell et al. Oct 1995 A
5456667 Ham et al. Oct 1995 A
5458568 Racchini et al. Oct 1995 A
5460607 Miyata et al. Oct 1995 A
5470314 Walinsky Nov 1995 A
5501694 Ressemann et al. Mar 1996 A
5524635 Uflacker et al. Jun 1996 A
5527282 Segal Jun 1996 A
5536178 Novelli Jul 1996 A
5545132 Fagan et al. Aug 1996 A
5556405 Lary Sep 1996 A
5556408 Farhat Sep 1996 A
5562620 Klein et al. Oct 1996 A
5569195 Saab Oct 1996 A
5571086 Kaplan et al. Nov 1996 A
5607442 Fischell et al. Mar 1997 A
5609574 Kaplan et al. Mar 1997 A
5616149 Barath Apr 1997 A
5620457 Pinchasik et al. Apr 1997 A
5624433 Radisch et al. Apr 1997 A
5628746 Clayman May 1997 A
5628755 Heller et al. May 1997 A
5643210 Iacob Jul 1997 A
5649941 Lary Jul 1997 A
5681281 Vigil et al. Oct 1997 A
5690642 Osborne et al. Nov 1997 A
5695469 Segal Dec 1997 A
5697944 Lary Dec 1997 A
5697971 Fischell et al. Dec 1997 A
5702410 Klunder et al. Dec 1997 A
5707385 Williams Jan 1998 A
5713863 Vigil et al. Feb 1998 A
5713913 Lary et al. Feb 1998 A
5718684 Gupta Feb 1998 A
5730698 Fischell et al. Mar 1998 A
5733303 Israel et al. Mar 1998 A
5735816 Lieber et al. Apr 1998 A
5742019 Radisch et al. Apr 1998 A
5755708 Segal May 1998 A
5755781 Jayaraman May 1998 A
5766201 Ravenscroft et al. Jun 1998 A
5766238 Lau et al. Jun 1998 A
5772681 Leoni Jun 1998 A
5776141 Klein et al. Jul 1998 A
5776181 Lee et al. Jul 1998 A
5792144 Fischell et al. Aug 1998 A
5792415 Hijlkema Aug 1998 A
5797935 Barath Aug 1998 A
5807355 Ramzipoor et al. Sep 1998 A
5810767 Klein Sep 1998 A
5814061 Osborne et al. Sep 1998 A
5827321 Roubin et al. Oct 1998 A
5863284 Klein Jan 1999 A
5868708 Hart et al. Feb 1999 A
5868719 Tsukernik Feb 1999 A
5868779 Ruiz Feb 1999 A
5868783 Tower Feb 1999 A
5869284 Cao et al. Feb 1999 A
5891090 Thornton Apr 1999 A
5902475 Trozera et al. May 1999 A
5904679 Clayman May 1999 A
5904698 Thomas et al. May 1999 A
5906639 Rudnick et al. May 1999 A
5916166 Reiss et al. Jun 1999 A
5919200 Stambaugh et al. Jul 1999 A
5954742 Osypka Sep 1999 A
5961490 Adams Oct 1999 A
5967984 Chu et al. Oct 1999 A
5980486 Enger Nov 1999 A
5987661 Peterson Nov 1999 A
5994667 Merdan et al. Nov 1999 A
6013055 Bampos et al. Jan 2000 A
6022359 Frantzen Feb 2000 A
6036686 Griswold Mar 2000 A
6036689 Tu et al. Mar 2000 A
6036708 Van Sciver Mar 2000 A
6048356 Ravenscroft et al. Apr 2000 A
6053913 Tu et al. Apr 2000 A
6059811 Pinchasik et al. May 2000 A
6071285 Lashinski et al. Jun 2000 A
6071286 Mawad Jun 2000 A
6077298 Tu et al. Jun 2000 A
RE36764 Zacca et al. Jul 2000 E
6102904 Vigil et al. Aug 2000 A
6106548 Roubin et al. Aug 2000 A
6117104 Fitz Sep 2000 A
6117153 Lary et al. Sep 2000 A
6123718 Tu et al. Sep 2000 A
6129706 Janacek Oct 2000 A
6129708 Enger Oct 2000 A
6136011 Stambaugh Oct 2000 A
6146323 Fischell Nov 2000 A
6152944 Holman et al. Nov 2000 A
6156254 Andrews et al. Dec 2000 A
6156265 Sugimoto Dec 2000 A
6165187 Reger Dec 2000 A
6190356 Bersin Feb 2001 B1
6190403 Fischell et al. Feb 2001 B1
6193686 Estrada et al. Feb 2001 B1
6203569 Wijay Mar 2001 B1
6206910 Berry et al. Mar 2001 B1
6210392 Vigil et al. Apr 2001 B1
6224625 Jayaraman May 2001 B1
6235043 Reiley et al. May 2001 B1
6241762 Shanley Jun 2001 B1
6245040 Inderbitzen et al. Jun 2001 B1
6258087 Edwards et al. Jul 2001 B1
6258099 Mareiro et al. Jul 2001 B1
6258108 Lary Jul 2001 B1
6261319 Kveen et al. Jul 2001 B1
6261630 Nazarova et al. Jul 2001 B1
6287336 Globerman et al. Sep 2001 B1
6289568 Miller et al. Sep 2001 B1
6296651 Lary et al. Oct 2001 B1
6306151 Lary Oct 2001 B1
6306166 Barry et al. Oct 2001 B1
6309414 Rolando et al. Oct 2001 B1
6312459 Huang et al. Nov 2001 B1
6319229 Kim et al. Nov 2001 B1
6319242 Patterson et al. Nov 2001 B1
6319251 Tu et al. Nov 2001 B1
6325779 Zedler Dec 2001 B1
6325813 Hektner Dec 2001 B1
6332880 Yang et al. Dec 2001 B1
6355013 van Muiden Mar 2002 B1
6355059 Richter et al. Mar 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6364856 Ding et al. Apr 2002 B1
6371961 Osborne et al. Apr 2002 B1
6394995 Solar et al. May 2002 B1
6416494 Wilkins Jul 2002 B1
6416539 Hassdenteufel Jul 2002 B1
6425882 Vigil Jul 2002 B1
6425908 Ravenscroft et al. Jul 2002 B2
6440158 Saab Aug 2002 B1
6447501 Solar et al. Sep 2002 B1
6450988 Bradshaw Sep 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6454775 Demarais et al. Sep 2002 B1
6471979 New et al. Oct 2002 B2
6475233 Trozera Nov 2002 B2
6475234 Richter et al. Nov 2002 B1
6475236 Roubin et al. Nov 2002 B1
6478807 Foreman et al. Nov 2002 B1
6500186 Lafontaine et al. Dec 2002 B2
6517765 Kelley Feb 2003 B1
6540722 Boyle et al. Apr 2003 B1
6551310 Ganz et al. Apr 2003 B1
6554795 Bagaoisan et al. Apr 2003 B2
6562062 Jenusaitis et al. May 2003 B2
6565528 Mueller May 2003 B1
6569180 Sirhan et al. May 2003 B1
6575993 Yock Jun 2003 B1
6585757 Callol Jul 2003 B1
6592548 Jayaraman Jul 2003 B2
6602281 Klein Aug 2003 B1
6605107 Klein Aug 2003 B1
6607442 Ogata et al. Aug 2003 B2
6613072 Lau et al. Sep 2003 B2
6616678 Nishtala et al. Sep 2003 B2
6626861 Hart et al. Sep 2003 B1
6632231 Radisch et al. Oct 2003 B2
6648912 Trout, III et al. Nov 2003 B2
6652548 Evans et al. Nov 2003 B2
6656351 Boyle Dec 2003 B2
6663660 Dusbabek et al. Dec 2003 B2
6695813 Boyle et al. Feb 2004 B1
6743196 Barbut et al. Jun 2004 B2
6746463 Schwartz Jun 2004 B1
6783542 Eidenschink Aug 2004 B2
6840950 Stanford et al. Jan 2005 B2
6872206 Edwards et al. Mar 2005 B2
6918920 Wang et al. Jul 2005 B1
6939320 Lennox Sep 2005 B2
6942680 Grayzel et al. Sep 2005 B2
6951566 Lary Oct 2005 B2
7011654 Dubrul et al. Mar 2006 B2
7011670 Radisch et al. Mar 2006 B2
7029483 Schwartz Apr 2006 B2
7060051 Palasis Jun 2006 B2
7131981 Appling et al. Nov 2006 B2
7172609 Radisch et al. Feb 2007 B2
7186237 Meyer et al. Mar 2007 B2
7232432 Fulton et al. Jun 2007 B2
7252650 Andrews et al. Aug 2007 B1
7303572 Melsheimer et al. Dec 2007 B2
7354445 Nicholson et al. Apr 2008 B2
7357813 Burgermeister Apr 2008 B2
7396358 Appling et al. Jul 2008 B2
7455652 Laird Nov 2008 B2
7465311 Wang et al. Dec 2008 B2
7494497 Weber Feb 2009 B2
7517352 Evans et al. Apr 2009 B2
7524319 Dubrul Apr 2009 B2
7566319 McAuley et al. Jul 2009 B2
7686824 Konstantino et al. Mar 2010 B2
7691119 Farnan Apr 2010 B2
7708748 Weisenburgh, II et al. May 2010 B2
7708753 Hardert May 2010 B2
7736375 Crow Jun 2010 B2
7763043 Goodin et al. Jul 2010 B2
7780715 Shaked et al. Aug 2010 B2
7780798 Stinson et al. Aug 2010 B2
7931663 Farnan et al. Apr 2011 B2
7955350 Konstantino et al. Jun 2011 B2
7963942 Chen Jun 2011 B2
7976557 Kunis Jul 2011 B2
7998184 Eidenschink Aug 2011 B2
8043259 Radisch et al. Oct 2011 B2
8052703 St. Martin et al. Nov 2011 B2
8066726 Kelley Nov 2011 B2
8080026 Konstantino et al. Dec 2011 B2
8123770 Olsen et al. Feb 2012 B2
8192675 Burton et al. Jun 2012 B2
8221444 Wang et al. Jul 2012 B2
8323307 Hardert Dec 2012 B2
8348987 Eaton Jan 2013 B2
8382820 Addonizio et al. Feb 2013 B2
8454637 Aggerholm et al. Jun 2013 B2
8574248 Kassab Nov 2013 B2
8685050 Schur et al. Apr 2014 B2
8685990 Coats et al. Apr 2014 B2
9199066 Konstantino et al. Dec 2015 B2
9351756 Gershony et al. May 2016 B2
9364254 Gershony et al. Jun 2016 B2
9375328 Farnan Jun 2016 B2
20010001113 Lim et al. May 2001 A1
20010001823 Ryan May 2001 A1
20010007082 Dusbabek et al. Jul 2001 A1
20010012950 Nishtala et al. Aug 2001 A1
20010016753 Caprio et al. Aug 2001 A1
20010031981 Evans Oct 2001 A1
20020010487 Evans et al. Jan 2002 A1
20020010489 Grayzel Jan 2002 A1
20020029015 Camenzind et al. Mar 2002 A1
20020038144 Trout, III et al. Mar 2002 A1
20020045930 Burg et al. Apr 2002 A1
20020065548 Birdsall et al. May 2002 A1
20020077606 Trotta Jun 2002 A1
20020111633 Stoltze et al. Aug 2002 A1
20020165599 Nasralla Nov 2002 A1
20020193873 Brucker et al. Dec 2002 A1
20030018376 Solar et al. Jan 2003 A1
20030023200 Barbut et al. Jan 2003 A1
20030028235 McIntosh et al. Feb 2003 A1
20030032973 Jenusaitis et al. Feb 2003 A1
20030065381 Solar et al. Apr 2003 A1
20030074046 Richter Apr 2003 A1
20030078606 Lafontaine et al. Apr 2003 A1
20030097169 Brucker et al. May 2003 A1
20030105509 Jang et al. Jun 2003 A1
20030114915 Mareiro et al. Jun 2003 A1
20030144683 Sirhan et al. Jul 2003 A1
20030149468 Wallsten Aug 2003 A1
20030153870 Meyer Aug 2003 A1
20030171799 Lee et al. Sep 2003 A1
20030187494 Loaldi Oct 2003 A1
20030195609 Berenstein et al. Oct 2003 A1
20030199970 Shanley Oct 2003 A1
20030199988 Devonec et al. Oct 2003 A1
20030208244 Stein et al. Nov 2003 A1
20030208255 O'Shaughnessy et al. Nov 2003 A1
20040034384 Fukaya Feb 2004 A1
20040111108 Farnan Jun 2004 A1
20040127475 New et al. Jul 2004 A1
20040133223 Weber Jul 2004 A1
20040143287 Konstantino et al. Jul 2004 A1
20040210299 Rogers et al. Oct 2004 A1
20040230293 Yip et al. Nov 2004 A1
20040243158 Konstantino et al. Dec 2004 A1
20050010278 Vardi et al. Jan 2005 A1
20050021070 Feld et al. Jan 2005 A1
20050021071 Konstantino et al. Jan 2005 A1
20050049677 Farnan Mar 2005 A1
20050083768 Hara Apr 2005 A1
20050131512 Vonderwalde Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050271844 Mapes et al. Dec 2005 A1
20060015133 Grayzel et al. Jan 2006 A1
20060074484 Huber Apr 2006 A1
20060085025 Farnan et al. Apr 2006 A1
20060112536 Herweck et al. Jun 2006 A1
20060129093 Jackson Jun 2006 A1
20060149308 Melsheimer et al. Jul 2006 A1
20060173487 Uflacker et al. Aug 2006 A1
20060184191 O'Brien Aug 2006 A1
20060247674 Roman Nov 2006 A1
20060259005 Konstantino et al. Nov 2006 A1
20060259062 Konstantino Nov 2006 A1
20060270193 Hidaka et al. Nov 2006 A1
20070112422 Dehdashtian May 2007 A1
20070185513 Woolfson et al. Aug 2007 A1
20070198047 Schon et al. Aug 2007 A1
20070213808 Roubin et al. Sep 2007 A1
20080300610 Chambers Dec 2008 A1
20090105686 Snow et al. Apr 2009 A1
20090105687 Deckman et al. Apr 2009 A1
20090264859 Mas Oct 2009 A1
20090281490 McAuley et al. Nov 2009 A1
20090306582 Granada et al. Dec 2009 A1
20100042121 Schneider et al. Feb 2010 A1
20100121372 Farnan May 2010 A1
20100179647 Carpenter et al. Jul 2010 A1
20100286720 Shaked et al. Nov 2010 A1
20100286721 Goodin et al. Nov 2010 A1
20110082483 Diamant et al. Apr 2011 A1
20110125247 Farnan et al. May 2011 A1
20110152905 Eaton Jun 2011 A1
20110160756 Aggerholm et al. Jun 2011 A1
20110264039 Thielen et al. Oct 2011 A1
20110270177 Chambers et al. Nov 2011 A1
20120059401 Konstantino et al. Mar 2012 A1
20120065660 Ferrera et al. Mar 2012 A1
20120215251 Burton et al. Aug 2012 A1
20120232638 Diamant et al. Sep 2012 A1
20120277626 Burbank et al. Nov 2012 A1
20130041391 Spencer et al. Feb 2013 A1
20130041399 Hardert Feb 2013 A1
20130060127 Burton et al. Mar 2013 A1
20130066346 Pigott Mar 2013 A1
20130096604 Hanson et al. Apr 2013 A1
20130150874 Kassab Jun 2013 A1
20130211381 Feld Aug 2013 A1
20130218181 Feld et al. Aug 2013 A1
20130226220 Konstantino et al. Aug 2013 A1
20130253554 Gershony et al. Sep 2013 A1
20130345730 Gershony et al. Dec 2013 A1
20140058358 Kassab Feb 2014 A1
20140066960 Feld et al. Mar 2014 A1
20140142598 Fulton et al. May 2014 A1
20150100079 Moffarah et al. Apr 2015 A1
20160331400 Gershony et al. Nov 2016 A1
20170086877 Moffarah et al. Mar 2017 A1
Foreign Referenced Citations (50)
Number Date Country
0565796 May 1997 EP
0623315 Jun 1999 EP
1169970 Jan 2002 EP
1 179 323 Feb 2002 EP
0832608 Mar 2003 EP
1042997 Mar 2005 EP
1581298 Aug 2006 EP
1414373 May 2008 EP
1337198 Jun 2009 EP
1748816 Jul 2010 EP
2063924 Oct 2010 EP
2283890 Feb 2011 EP
1962696 Mar 2012 EP
1737530 Mar 2013 EP
2564890 Mar 2013 EP
H06505416 Jun 1994 JP
2002126086 May 2002 JP
2002126086 May 2002 JP
2004504111 Feb 2004 JP
2004148013 May 2004 JP
2007502694 Feb 2007 JP
2007530158 Nov 2007 JP
2011528963 Dec 2011 JP
2011529350 Dec 2011 JP
WO1991002494 Mar 1991 WO
9217118 Oct 1992 WO
WO1993001753 Feb 1993 WO
WO1994010919 May 1994 WO
WO 9423787 Oct 1994 WO
WO1994023787 Oct 1994 WO
WO1994024946 Nov 1994 WO
WO1995003083 Feb 1995 WO
WO 9805377 Feb 1998 WO
WO 9805377 Feb 1998 WO
WO1998045506 Oct 1998 WO
1999017680 Apr 1999 WO
1999055253 Nov 1999 WO
1999062430 Dec 1999 WO
02083011 Oct 2002 WO
WO2002083011 Oct 2002 WO
WO2003026536 Apr 2003 WO
WO 0304176 May 2003 WO
WO2003039628 May 2003 WO
WO2004028610 Apr 2004 WO
WO2004060460 Jul 2004 WO
WO2004066852 Aug 2004 WO
WO2005025458 Mar 2005 WO
2009150099 Dec 2009 WO
2012040225 Mar 2012 WO
2015054277 Apr 2015 WO
Non-Patent Literature Citations (37)
Entry
PCT Search Report for International Application No. PCT/US04/27836, dated Dec. 30, 2004 by Jackie Tan-Uyen T. Ho.
PCT Search Report for International Application No. PCT/US2002/035547, dated May 20, 2003 by Jacki Tan-Uyen T. Ho.
European search report and search opinion dated May 4, 2010 for EP 06770116.9.
European search report and search opinion dated Dec. 28, 2009 for EP 05792875.6.
Extended European Search Report issued in EP Application No. 11827369.7, dated Apr. 7, 2014. 6 pages.
File History for U.S. Appl. No. 13/044,425, filed Mar. 9, 2011.
First Examination Report dated Feb. 5, 2014 from corresponding EP Application No. 05733012.8.
International search report and written opinion dated Feb. 27, 2007 for PCT/US2006/017872.
International search report and written opinion dated May 23, 2006 for PCT /2005/009571.
International search report and written opinion dated Jul. 26, 2007 for PCT/2005/028809.
International search report and written opinion dated Nov. 4, 2004 for PCT/2004/000177.
International Search Report and Written Opinion issued in PCT/US2011/052392 dated Jan. 11, 2012, 7 pages.
International Search Report issued in PCT/US2002/035547dated May 20, 2003, 3 Pages.
Japanese office action dated Jul. 9, 2010 for JP 2007-505113. (in Japanese with English translation).
Supplementary European Search Report dated Nov. 20, 2013 from corresponding EP Application No. 05733012.8.
AngioScore, Inc. v. Trireme Medical LLC et al, Fourth Amended Complaint for: 1) Patent Infringement; 2) Breach of Fiduciary Duty Under California Law; 3) Breach of Fiduciary Duty; Under Delaware Law; 4) Aiding and Abetting a Breach of Fiduciary Duty; and 5) Unfair Competition Under California Business and Professional Cos ss 17200, filed in the United States District Court, Northern District of California, Oakland Division, on Jul. 15, 2014, Case No. 4:12-cv-3393-YGR.
Exhibit A to AngioScore, Inc. v. Trireme Medical, LLC, Fourth Amended Complaint filed Jul. 15, 2014, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR.
AngioScore, Inc. v. Trireme Medical, LLC, Order Construing Claims in Dispute; Granting in Part and Denying in Part Defendants' Motion for Summary Judgment of Non-Infrignment, filed Jun. 25, 2014, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR.
AngioScore, Inc. v. Trireme Medical, LLC, Partial Portion of Reporter's Transcript of Proceedings, Sep. 21, 2015, vol. 12, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (including testimony by Robert Farnan).
AngioScore, Inc. v. Trireme Medical, LLC, Partial Portion of Reporter's Transcript of Proceedings, Sep. 22, 2015, vol. 13, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (including testimony by Ali Almedhychy).
AngioScore, Inc. v. Trireme Medical, LLC, Partial Portion of Reporter's Transcript of Proceedings, vol. 14, Sep. 28, 2015, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (including testimony by Michael Horzewski, jury instructions including meaning of claim terms, and closing arguments).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4222, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (U.S. Pat. No. 5,797,935 to Barath).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4224, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (U.S. Pat. No. 5,868,783 to Tower).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4268, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (U.S. Pat. No. 5,730,698 to Fischell et al.).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4272, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (U.S. Pat. No. 6,059,811 to Pinchasik et al.).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4273, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (U.S. Pat. No. 6,261,319 to Kveen et al.).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4274, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (U.S. Pat. No. 6,416,539 to Hassdenteufel).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4315, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (Zarge, et al., Chapter 17: Balloon Angioplasty, in Peripheral Endovascular Insterventions (1996)).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4362, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR, (Palmaz, et al., “Atherosclerotic Rabbit Aortas: Expandable Intraluminal Giafling,” Radiology, Sep. 1986, pp. 724-726).
AngioScore, Inc. v. Trireme Medical, LLC, Defendant's Exhibit DX4473, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR (U.S. Pat. No. 5,196,024 to Barath).
AngioScore, Inc. v. Trireme Medical, LLC, Verdict Form filed Sep. 29, 2015, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR.
AngioScore, Inc. v. Trireme Medical, LLC, Judgement as Modified by the Court, filed Oct. 14, 2015, United States District Court, Northern District of California, Oakland Division, Case No. 4:12-cv-3393-YGR.
File History for U.S. Appl. No. 13/022,489, filed Feb. 7, 2011 entitled Balloon Catheter With Non-Deployable Stent.
FFile History for U.S. Appl. No. 12/694,163, filed Jan. 26, 2010 entitled Balloon Catheter With Non-Deployable Stent.
International Preliminary Report on Patentability issued in PCT/US2014/059525, dated Apr. 21, 2016, 5 pages.
Trireme Medical, LLC v. AngioScore, Inc., Decision on Appeal dated Feb. 5, 2016, United States Court of Appeals for the Federal Circuit, Case No. 2015-1504.
Extended European Search Report issued in EP Application 14852692.4, dated May 4, 2017, 12 pages.
Related Publications (1)
Number Date Country
20120245616 A1 Sep 2012 US
Provisional Applications (1)
Number Date Country
60344982 Nov 2001 US
Continuations (3)
Number Date Country
Parent 13022489 Feb 2011 US
Child 13489250 US
Parent 11292426 Dec 2005 US
Child 13022489 US
Parent 10651557 Aug 2003 US
Child 11292426 US
Continuation in Parts (1)
Number Date Country
Parent 10399589 US
Child 10651557 US